Equities

Health Advance Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
HADV:PKC

Health Advance Inc

Actions
Consumer DiscretionaryConsumer Discretionary
  • Price (USD)0.0004
  • Today's Change0.000 / 100.00%
  • Shares traded7.87m
  • 1 Year change-42.86%
  • Beta0.4499
Data delayed at least 15 minutes, as of Feb 13 2026 20:57 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Health Advance, Inc. is focused on cannabidiol (CBD) infused dealcoholized wine beverage products and nutraceutical product range. Its principal products or services include CBD or other cannabis derivatives infused into beverages, immune boosting nutraceutical in viability analysis and market research stage, consulting in the marketing and distribution fields of human wellness, and healthcare equipment.

  • Revenue in USD (TTM)--
  • Net income in USD--
  • Incorporated2010
  • Employees3.00
  • Location
    Health Advance Inc685 Citadel Drive East, Suite 290COLORADO SPRINGS 80909United StatesUSA
  • Phone+1 (719) 466-6699
  • Fax+1 (702) 943-0233
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Greater Cannabis Company Inc0.00-573.81k246.63k1.00---------0.4959-0.49590.00-1.230.00----0.00-1,345.24-211.02-------0.1319---3,759.87---22.67--------4.97------
THC Farmaceuticals Inc7.58k-60.45k362.63k2.00--0.1417--47.84-0.0036-0.00360.00050.1411------3,790.00--------100.00---1,591.69------0.2051--348.43--5,170.19------
Health Advance Inc-100.00bn-100.00bn382.33k3.00--0.0189----------0.0212----------------------------0.0356--100.00---21.75------
Windtree Therapeutics Inc0.00-48.83m394.39k14.00---------8.38-8.380.00-0.34490.00----0.00-172.27-48.72-791.65-52.57------------22.36------72.96---42.51--
Avenue Therapeutics Inc1.40m-3.74m477.51k2.00--0.1343--0.3401-1.55-1.550.501.120.4422----702,000.00-119.06-159.81-122.59-215.40-----269.23------0.00-------12.29------
Regenerative Medical Technology Grop Inc5.04m-7.06m512.42k1.00------0.1017-0.5629-0.56290.4019-2.401.3024.9569.50---182.18-177.25----59.7664.83-140.06-465.060.0784-0.0279----70.44167.3043.31------
Bio Path Holdings Inc0.00-11.18m536.04k10.00---------1.71-1.710.00-0.8660.00----0.00-611.66-81.00---90.58-----------65.76--------38.46------
Longevity Health Holdings Inc1.46m-5.74m545.07k15.00------0.374-5.22-5.221.26-2.230.50771.1147.3197,153.34-199.84------57.86---393.63--0.2676----------36.91------
Novelstem International Corp3.00k2.31m562.58k15.000.2495----187.530.04810.04810.00006-0.04380.0281--0.80--630.69----------22,424.33----------0.00--22.79------
Data as of Feb 13 2026. Currency figures normalised to Health Advance Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.